These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9197354)

  • 1. Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: a randomized trial.
    Frantz RP; Edwards BS; Olson LJ; Schwab MK; Adams TF; Textor SC; Daly RC; McGregor CG; Rodeheffer RJ
    Transplantation; 1997 Jun; 63(11):1607-10. PubMed ID: 9197354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline reduces nephrotoxicity associated with cyclosporine in the rat by its rheological properties.
    Albornoz LE; Sanchez SB; Bandi JC; Canteros G; de las Heras M; Mastai RC
    Transplantation; 1997 Nov; 64(10):1404-7. PubMed ID: 9392302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients.
    Chan C; Maurer J; Cardella C; Cattran D; Pei Y
    Transplantation; 1997 May; 63(10):1435-40. PubMed ID: 9175807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid withdrawal improves blood pressure control and nocturnal dipping in pediatric renal transplant recipients: analysis of a prospective, randomized, controlled trial.
    Höcker B; Weber LT; John U; Drube J; Fehrenbach H; Klaus G; Pohl M; Seeman T; Fichtner A; Wühl E; Tönshoff B
    Pediatr Nephrol; 2019 Feb; 34(2):341-348. PubMed ID: 30178240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.
    Mourad G; Vela C; Ribstein J; Mimran A
    Transplantation; 1998 Mar; 65(5):661-7. PubMed ID: 9521200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of pentoxifylline on cyclosporine-induced nephrotoxicity.
    Kaputlu I; Sadan G; Karayalçin B; Boz A
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):365-9. PubMed ID: 9143789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
    Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
    J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension prophylaxis with omega-3 fatty acids in heart transplant recipients.
    Andreassen AK; Hartmann A; Offstad J; Geiran O; Kvernebo K; Simonsen S
    J Am Coll Cardiol; 1997 May; 29(6):1324-31. PubMed ID: 9137231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation.
    Carrier M; Pelletier GB; White M; Bois D; Pelletier LC
    J Heart Lung Transplant; 1996 Dec; 15(12):1179-83. PubMed ID: 8981202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of renal dysfunction and hypertension by amlodipine after heart transplant.
    Leenen FH; Coletta E; Davies RA
    Am J Cardiol; 2007 Aug; 100(3):531-5. PubMed ID: 17659942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients.
    Chanard J; Toupance O; Lavaud S; Hurault de Ligny B; Bernaud C; Moulin B
    Nephrol Dial Transplant; 2003 Oct; 18(10):2147-53. PubMed ID: 13679494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients.
    Koller-Strametz J; Wolzt M; Fuchs C; Putz D; Wisser W; Mensik C; Eichler HG; Laufer G; Schmetterer L
    Kidney Int; 1999 May; 55(5):1871-7. PubMed ID: 10231449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
    Lipkin GW; Thuraisingham R; Dawnay AB; Harwood SM; Raine AE
    Transplantation; 1997 Oct; 64(7):1007-17. PubMed ID: 9381523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunction.
    Pollak R; Knight R; Mozes MF; Maddux M; Veremis S; Van Buren C; Lewis R; Scott E; Cole M; Hyndman V
    Am J Kidney Dis; 1992 Oct; 20(4):336-41. PubMed ID: 1415200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial.
    Andreassen AK; Broch K; Eiskjær H; Karason K; Gude E; Mølbak D; Stueflotten W; Gullestad L;
    Transplantation; 2019 Apr; 103(4):781-788. PubMed ID: 30211826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine nephrotoxicity in the ischemic kidney and the protective effect of pentoxifylline--a study in the rat.
    Ates E; Sharma P; Erkasap S; Talbot D; Ihtiyar E; Yasar B; Kiper H
    Transplantation; 1996 Sep; 62(6):864-7. PubMed ID: 8824491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients.
    Hartmann A; Andereassen AK; Holdaas H; Simonsen S; Geiran O; Berg KJ
    J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.